- Home
- VRDN vs BASE Comparison
VRDN vs BASE Comparison
Compare VRDN & BASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- BASE
- Stock Information
- Founded
- VRDN 2006
- BASE 2011
- Country
- VRDN United States
- BASE United States
- Employees
- VRDN N/A
- BASE N/A
- Industry
- VRDN Medical Specialities
- BASE EDP Services
- Sector
- VRDN Health Care
- BASE Technology
- Exchange
- VRDN Nasdaq
- BASE Nasdaq
- Market Cap
- VRDN 1.3B
- BASE 1.3B
- IPO Year
- VRDN N/A
- BASE 2021
- Fundamental
- Price
- VRDN $17.28
- BASE $24.27
- Analyst Decision
- VRDN Strong Buy
- BASE Hold
- Analyst Count
- VRDN 11
- BASE 16
- Target Price
- VRDN $38.50
- BASE $22.97
- AVG Volume (30 Days)
- VRDN 667.1K
- BASE 806.8K
- Earning Date
- VRDN 08-07-2025
- BASE 09-03-2025
- Dividend Yield
- VRDN N/A
- BASE N/A
- EPS Growth
- VRDN N/A
- BASE N/A
- EPS
- VRDN N/A
- BASE N/A
- Revenue
- VRDN $302,000.00
- BASE $214,662,000.00
- Revenue This Year
- VRDN N/A
- BASE $12.41
- Revenue Next Year
- VRDN $17,102.33
- BASE $13.95
- P/E Ratio
- VRDN N/A
- BASE N/A
- Revenue Growth
- VRDN 4.86
- BASE 12.76
- 52 Week Low
- VRDN $9.90
- BASE $12.78
- 52 Week High
- VRDN $27.20
- BASE $25.16
- Technical
- Relative Strength Index (RSI)
- VRDN 60.64
- BASE 71.37
- Support Level
- VRDN $16.46
- BASE $24.20
- Resistance Level
- VRDN $18.44
- BASE $24.32
- Average True Range (ATR)
- VRDN 0.81
- BASE 0.12
- MACD
- VRDN 0.04
- BASE -0.23
- Stochastic Oscillator
- VRDN 57.82
- BASE 40.00
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About BASE Couchbase Inc.
Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud. Geographically, the company generates a majority of its revenue from the United States.